Acerus Pharmaceuticals Corporation (ASP.TO)
Company Info
| ISIN | CA00444G4051 |
|---|---|
| CUSIP | 00444G405 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
ASP.TOShare Price Chart
Loading data...
ASP.TOPerformance
The chart shows the growth of CA$10,000 invested in Acerus Pharmaceuticals Corporation in Feb 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$99,231 for a total return of roughly 892.31%. All prices are adjusted for splits and dividends.
ASP.TOCompare to other instruments
ASP.TOReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | -26.29% | 4.33% |
| 6M | -67.34% | -0.80% |
| YTD | -78.50% | -17.60% |
| 1Y | -83.88% | -17.53% |
| 5Y | -54.34% | 5.97% |
| 10Y | -44.10% | 9.17% |
ASP.TOMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 66.67% | -20.00% | 25.00% | -51.40% | -17.70% | -22.50% | -3.23% | 8.33% | -43.08% | -2.70% | -28.33% | |
| 2021 | 0.00% | 25.00% | 20.00% | -16.67% | 0.00% | 0.00% | -20.00% | 0.00% | 0.00% | 0.00% | 0.00% | -25.00% |
| 2020 | -12.50% | -14.29% | -16.67% | 0.00% | 20.00% | 0.00% | 0.00% | -16.67% | 0.00% | -20.00% | 0.00% | 0.00% |
| 2019 | 0.00% | 8.33% | 23.08% | 6.25% | -17.65% | -21.43% | 27.27% | -14.29% | -8.33% | -18.18% | -22.22% | 14.29% |
| 2018 | 6.90% | -16.13% | 3.85% | 33.33% | -5.56% | -29.41% | 0.00% | 12.50% | -7.41% | -12.00% | -31.82% | -20.00% |
| 2017 | 0.00% | -7.14% | -15.38% | 9.09% | -8.33% | 18.18% | -15.38% | -0.00% | -0.00% | 9.09% | 208.33% | -21.62% |
| 2016 | 0.00% | -16.67% | 60.00% | 18.75% | -26.32% | -21.43% | -0.00% | 100.00% | -13.64% | 5.26% | -30.00% | 0.00% |
| 2015 | 2.86% | 5.56% | 2.63% | -16.67% | 3.08% | 1.49% | -29.41% | -4.17% | -32.61% | -6.45% | -55.17% | -7.69% |
| 2014 | 92.50% | 7.79% | -16.87% | -28.99% | 71.43% | -16.67% | -14.29% | -21.67% | -19.15% | 15.79% | 20.45% | 32.08% |
| 2013 | -15.71% | 6.83% | -54.07% | 41.77% | -31.25% | -6.49% | 23.61% | -7.87% | -0.00% | -51.22% | 25.00% | -20.00% |
| 2012 | -0.00% | 100.00% | -10.00% | 26.98% | -20.25% | -49.53% | -0.62% | 5.63% | -7.69% | 30.13% | -0.49% | -5.45% |
| 2011 | 0.00% | 20.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.99% | 15,089.87% | 12.50% | 14.81% | 20.00% | -5.91% |
| 2010 | 0.00% | 0.00% | 981.77% | -9.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ASP.TODividend History
Acerus Pharmaceuticals Corporation doesn't pay dividends
ASP.TODrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ASP.TOWorst Drawdowns
The table below shows the maximum drawdowns of the Acerus Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Acerus Pharmaceuticals Corporation is 99.86%, recorded on Nov 25, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.86% | Apr 16, 2012 | 2665 | Nov 25, 2022 | — | — | — |
| -90.22% | Jan 27, 2011 | 3 | Feb 2, 2011 | 3 | Jul 19, 2011 | 6 |
| -48.89% | Jul 20, 2011 | 20 | Aug 18, 2011 | 3 | Aug 23, 2011 | 23 |
| -20% | Oct 3, 2011 | 3 | Oct 5, 2011 | 3 | Oct 11, 2011 | 6 |
| -18.82% | Dec 2, 2011 | 13 | Dec 20, 2011 | 31 | Feb 6, 2012 | 44 |
| -15.67% | Feb 17, 2012 | 7 | Feb 28, 2012 | 30 | Apr 11, 2012 | 37 |
| -15.2% | Aug 25, 2011 | 13 | Sep 13, 2011 | 6 | Sep 21, 2011 | 19 |
| -9.43% | Nov 22, 2011 | 2 | Nov 23, 2011 | 2 | Nov 25, 2011 | 4 |
| -9.09% | May 4, 2010 | 1 | May 4, 2010 | 1 | Jan 6, 2011 | 2 |
| -9.09% | Jan 7, 2011 | 1 | Jan 7, 2011 | 2 | Jan 18, 2011 | 3 |
ASP.TOVolatility Chart
Current Acerus Pharmaceuticals Corporation volatility is 120.58%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.